Immatics (NASDAQ:IMTX) reported $7.40 million in sales this quarter. This is a 18.68 percent decrease over sales of $9.10 million the same period last year.
The Drugs Controller General of India has Recommended Emergency Use Authorization for Bharat Biotech’s Covaxin for Children 6 to 12 Years of Age
https://twitter.com/CNBCTV18News/status/1518877996442001408